Monocyte chemoattractant protein‐1 is a mediator of the anabolic action of parathyroid hormone on bone

Parathyroid hormone (PTH) has a significant role as an anabolic hormone in bone when administered by intermittent injection. Previous microarray studies in our laboratory have shown that the most highly regulated gene, monocyte chemoattractant protein‐1 (MCP‐1), is rapidly and transiently induced when hPTH(1‐34) is injected intermittently in rats. Through further in vivo studies, we found that rats treated with hPTH(1‐34) showed a significant increase in serum MCP‐1 levels 2 hours after PTH injection compared with basal levels. Using immunohistochemistry, increased MCP‐1 expression in osteoblasts and osteocytes is evident after PTH treatment. PTH also increased the number of marrow macrophages. MCP‐1 knockout mice injected daily with hPTH(1‐34) showed less trabecular bone mineral density and bone volume compared with wild‐type mice as measured by peripheral quantitative computed tomography (pQCT) and micro‐computed tomography (µCT). Histomorphometric analysis revealed that the increase in osteoclast surface and osteoclast number observed with intermittent PTH treatment in the wild‐type mice was completely eliminated in the MCP‐1 null mice, as well as much lower numbers of macrophages. Consequently, the lack of osteoclast and macrophage activity in the MCP‐1 null mice was paralleled by a reduction in bone formation. We conclude that osteoblast and osteocyte MCP‐1 expression is an important mediator for the anabolic effects of PTH on bone.